Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles

PURPOSE: Schisandrin B (Sch B) is clinically applied for the treatment of hepatitis and ischemic disease. However, its clinical efficacy is limited due to the poor solubility and low bioavailability. This study aimed to develop matrix metalloproteinase (MMP)-sensitive peptide-modified, polyethylene...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Mingfeng, Yang, Wenfang, Han, Guangying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627750/
https://www.ncbi.nlm.nih.gov/pubmed/29026305
http://dx.doi.org/10.2147/IJN.S141549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627750/
https://www.ncbi.nlm.nih.gov/pubmed/29026305
http://dx.doi.org/10.2147/IJN.S141549

Ejemplares similares